Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Cognitive rehabilitation for patients with multiple sclerosis

Official title: Cognitive Rehabilitation of Deficits in Patients With Multiple Sclerosis: Proposal for an Integrated Cognitive Treatment in a Telematic Format

Run by Universita di Verona · NCT06964581 · Data updated 2026-11-12

This study tests whether a computer-based cognitive treatment delivered online can help people with multiple sclerosis just as much as in-person therapy.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment60 (estimated)
SponsorUniversita di Verona
Academic / other
Locations1 site (Verona, verona)
StatusRecruiting
StartedFebruary 8, 2023
Main results expectedApril 22, 2025
Study endsSeptember 30, 2025
Registry record updatedMay 9, 2025
Trial IDNCT06964581 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 with a diagnosis of multiple sclerosis and specific cognitive disorders.

Probably not a fit

Patients with other neurological conditions, psychiatric disorders, or severe uncorrected visual deficits may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a computer-based cognitive treatment delivered through telerehabilitation compared to in-person treatment for patients with multiple sclerosis. It is a non-inferiority, single-blind randomized controlled trial that focuses on sustained attention and other cognitive functions. The study includes patients diagnosed with relapsing-remitting, primary progressive, or secondary progressive multiple sclerosis, and assesses various cognitive disorders. The aim is to determine if telerehabilitation can provide similar benefits to traditional in-person therapy.

Why it matters

Potential benefit: If successful, this approach could provide accessible cognitive rehabilitation options for patients with multiple sclerosis, improving their cognitive functions and quality of life.

How similar studies have gone: Other studies have shown promising results with telerehabilitation approaches for cognitive disorders, suggesting potential success for this method.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of relapsing-remitting multiple sclerosis (RRMS), or primary progressive (PPMS) or secondary progressive (SPMS), defined by at least 3-6 months.
* Age between 18 and 65 years.
* Expanded Disability Status Scale (EDSS) between 3 and 5 to include patients with overall neurological disability from mild to moderate.
* Presence of one or more of the following cognitive disorders (reported by the patient and subsequently confirmed through the Oxford Cognitive Screen-OCS):
* Memory disorders
* Attention disorders
* Executive function disorders
* Availability of internet at the patient's home necessary for the tele-rehabilitation procedures.
* Adequate visual and auditory abilities to use the rehabilitation device.

Exclusion Criteria:

* Presence of other neurological conditions;
* Psychiatric disorders in medical history;
* Alcohol and/or drug abuse;
* Presence of uncorrected severe visual deficits.

Where it's running

  • Azienda Ospedaliera Universitaria Integrata Verona - UOC di Neuroriabilitazione
    Verona, verona, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.